Evidence map›Paper›PMID 27543072›Full record

ArticleThe Journal of allergy and clinical immunology2016

IL-22 derived from γδ T cells restricts Staphylococcus aureus infection of mechanically injured skin.

Nidhi Malhotra, Juhan Yoon, Juan Manuel Leyva-Castillo, Claire Galand, Nathan Archer, Lloyd S Miller, Raif S Geha

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. I don't know about you, but I'm feeling IL-22.Cytokine & growth factor reviews · 2024
    Review
  4. Article
  5. Article
  6. The extracellular serine protease fromFrontiers in immunology · 2024
    Article
  7. Article
  8. Article
  9. Advanced In Vitro Three-Dimensional Skin Models of Atopic Dermatitis.Tissue engineering and regenerative medicine · 2023
    Review
  10. Article
  11. Article
  12. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.JID innovations : skin science from molecules to population health · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Update on the Pathogenesis and Therapy of Atopic Dermatitis.Clinical reviews in allergy & immunology · 2021
    Review
  17. Article
  18. Chronic UV radiation-induced RORγt+ IL-22-producing lymphoid cells are associated with mutant KC clonal expansion.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Nidhi MalhotraDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass.
Juhan YoonDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass.
Juan Manuel Leyva-CastilloDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass.
Claire GalandDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass.
Nathan ArcherDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Md.
Lloyd S MillerDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Md.
Raif S GehaDivision of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: Raif.geha@childrens.harvard.edu.
Harvard University · USBoston Children's Hospital · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Targeted Microbiome Transplant in Atopic DermatitisU19AI117673 · NIAID · NATIONAL JEWISH HEALTH · PI GEHA, RAIF SALIM · 2015 to 2019
$30.6M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
The Next Generation Immunoanalysis CoreP30AR069625 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2016 to 2025
$8.8M
STAT3-mediated immunity to Staphylococcus aureus in skinR01AR069502 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2016 to 2020
$1.8M
NIAID NIH HHS HHSN272201000020CNIAID NIH HHS HHSN272201000020INIAID NIH HHS U01 AI147462NIAID NIH HHS U19 AI117673NIAMS NIH HHS P30 AR069625NIAMS NIH HHS R01 AR069502
6 · The paper itself

Abstract

backgroundStaphylococcus aureus is an opportunistic pathogen that colonizes the skin of patients with atopic dermatitis (AD) and aggravates their disease. Neutrophils and the cytokines IL-17A and IL-17F, which drive the expression of the neutrophil-attracting chemokines, are important for the clearance of S aureus infection. The cytokine IL-22 is often coproduced by IL-17-secreting cells. The levels of IL-22 are elevated in AD skin lesions.

objectiveWe sought to determine the role of IL-22 in the clearance of S aureus infection of mouse skin subjected to tape stripping, a surrogate for scratching, a cardinal feature of AD.

methodsS aureus was applied to the tape-stripped skin of wild-type and Il22

resultsScratching the skin of healthy adults and tape stripping of mouse skin induced local expression of Il22 mRNA and IL-22 protein. Induction of Il22 expression by tape stripping was dependent on IL-23 and γδ T cells. Clearance of S aureus from tape-stripped skin was significantly impaired in Il22

conclusionsThese findings show that IL-22 is important for limiting the growth of S aureus on mechanically injured skin and caution that IL-23 and IL-22 blockade in patients with AD may enhance susceptibility to staphylococcal skin infection.

Indexed as

AnimalsDermatitis, AtopicFlow CytometryHumansInterleukin-22InterleukinsMiceSkinStaphylococcal Skin InfectionsStaphylococcus aureusT-LymphocytesInterleukin-22InterleukinsADIL-22neutrophilsS aureus

Identifiers

PMID27543072
PMCPMC5056816
OpenAlexW2462669708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.